Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Change in Accured Expenses came in at -$2.2 million in Q3 2025, down 778.06% year-on-year from $319000.0 in Q3 2024, and up 13.55% on a QoQ basis from -$2.5 million in Q2 2025.
Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Change in Accured Expenses data on file, last reported at -$2.2 million in Q3 2025.
- On a quarterly basis, Change in Accured Expenses fell 778.06% year-over-year to -$2.2 million in Q3 2025; TTM through Sep 2025 was -$4.1 million, a 1530.16% decrease from a year earlier, with the FY2024 full-year figure at $309000.0, up 137.09% from the prior year.
- Change in Accured Expenses for Q3 2025 stood at -$2.2 million, up from -$2.5 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for RBOT reached as high as $2.8 million in Q4 2021 and fell as low as -$2.5 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $27000.0 across 5 years, with a median of $287000.0 in 2025.
- On a YoY basis, Change in Accured Expenses climbed as much as 10227.55% in 2021 and fell as far as 5779.1% in 2021.
- Year by year, Change in Accured Expenses stood at $2.8 million in 2021, then plunged by 84.42% to $443000.0 in 2022, then slumped by 165.69% to -$291000.0 in 2023, then surged by 192.78% to $270000.0 in 2024, then slumped by 901.11% to -$2.2 million in 2025.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$2.2 million in Q3 2025, -$2.5 million in Q2 2025, and $287000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.16 Mn |
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | 287,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -291,000.00 |
| Dec 31, 2023 | -291,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |